BridgeBio Pharma, Inc. (BBIO) stock
BBIONasdaqPharmaceutical PreparationsFiscal year ends December 31
$78.01+1.21 (+1.58%)
Close on Nov 18, 2026Market cap $15.20BP/E –Yield –
BridgeBio Pharma net income
Net income is the profit left for shareholders after every expense, interest and tax.
Quarterly net income
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | -$56.71M | – |
| Q3 FY2025 | Sep 30, 2025 | -$182.74M | – |
See a number that looks wrong?